Have a personal or library account? Click to login
The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2 Cover

The Effect of Bevacizumab on Vestibular Schwannoma Related to Neurofibromatosis Type 2

Australasian Journal of Neuroscience
Volume 31 (2021): Issue 1 (May 2021)
By: Simone Ardern-Holmes,  Cassandra White,  Sarita Bahure,  Simon So,  Geoff McCowage,  Elizabeth Hovey,  Simon Troon,  Paul De Souza,  John Simes,  Michael Slancar,  Mark Dexter and  Mark Wong  
Open Access
|May 2021
DOI: https://doi.org/10.21307/ajon-2021-002 | Journal eISSN: 2208-6781 | Journal ISSN: 1032-335X
Journal RSS Feed
Language: English
Page range: 5 - 14
Published on: May 1, 2021
Published by: Australasian Neuroscience Nurses Association
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Bevacizumab,
Vestibular Schwannoma,
Neurofibromatosis Type 2,
3-D Volumetric Analysis,
Audiometry
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other

© 2021 Simone Ardern-Holmes, Cassandra White, Sarita Bahure, Simon So, Geoff McCowage, Elizabeth Hovey, Simon Troon, Paul De Souza, John Simes, Michael Slancar, Mark Dexter, Mark Wong, published by Australasian Neuroscience Nurses Association
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 31 (2021): Issue 1 (May 2021)Next article